Morgan Stanley’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
637,707
+200,168
| +46% | +$3.63M | ﹤0.01% | 3307 |
|
|
2025
Q1 | $8.96M | Buy |
437,539
+7,437
| +2% | +$152K | ﹤0.01% | 3444 |
|
|
2024
Q4 | $11.1M | Buy |
430,102
+226,897
| +112% | +$5.83M | ﹤0.01% | 3314 |
|
|
2024
Q3 | $3.37M | Buy |
203,205
+178,513
| +723% | +$2.96M | ﹤0.01% | 4265 |
|
|
2024
Q2 | $474K | Sell |
24,692
-152,896
| -86% | -$2.94M | ﹤0.01% | 5315 |
|
|
2024
Q1 | $4.2M | Buy |
177,588
+120,512
| +211% | +$2.85M | ﹤0.01% | 4044 |
|
|
2023
Q4 | $638K | Buy |
57,076
+55,374
| +3,253% | +$619K | ﹤0.01% | 5519 |
|
|
2023
Q3 | $15.7K | Buy |
1,702
+894
| +111% | +$8.27K | ﹤0.01% | 6555 |
|
|
2023
Q2 | $9.61K | Buy |
808
+305
| +61% | +$3.63K | ﹤0.01% | 6826 |
|
|
2023
Q1 | $6.67K | Buy |
+503
| New | +$6.67K | ﹤0.01% | 6994 |
|